Burleson & Company »

GSK shares owned by Burleson & Company

Quarter-by-quarter ownership of GSK (GSK) shares owned by Burleson & Company from 13F filings

Historical chart of Burleson & Company investment in GSK

Tip: Access up to 7 years of quarterly data

All positions including GSK held by Burleson & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in GSK by Burleson & Company

Quarter filed Position value Share count Share price at filing
2022-12-31 $13k 366 35.14
2022-09-30 $11k 366 30.05

More positions owned by Burleson & Company

Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Uber Technologies (UBER)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Burleson & Company

Top funds holding GSK

Dodge & Cox
JTC Employer Solutions Trustee
Fisher Investments
PRIMECAP Management Company
Morgan Stanley
T. Rowe Price Associates
Royal Bank of Canada
State Street Corporation
Mondrian Investment Partners
Goldman Sachs Group
Acadian Asset Management
Provident Trust
Arrowstreet Capital, Limited Partnership
Hsbc Holdings
Hotchkis and Wiley Capital Management

View all funds holding GSK